Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

86.34
Delayed Data
As of Jun 23
 0.00 / 0.00%
Today’s Change
66.93
Today|||52-Week Range
86.90
+18.53%
Year-to-Date
Regeneron (REGN) Stock on Fire: What's Behind the Surge?
Jun 23 / Zacks.com - Paid Partner Content
Gilead's (GILD) HBV Drug Vemlidy Receives Approval in Canada
Jun 20 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: NVS Scores with Positive Data, Shire ADHD Drug Gets FDA Nod
Jun 23 / Zacks.com - Paid Partner Content
Amgen's Xgeva Myeloma Label Expansion sBLA Accepted by FDA
Jun 20 / Zacks.com - Paid Partner Content
Healthcare Rally Can't Save S&P 500 From Another Down Day
Jun 22 / TheStreet.com - Paid Partner Content
Novartis (NVS) Biosimilar of MabThera Approved in the EU
Jun 19 / Zacks.com - Paid Partner Content
Nasdaq Leads Wall Street, Healthcare Stocks Rise on Senate Bill
Jun 22 / TheStreet.com - Paid Partner Content
3 Biotech Stocks That More than Doubled Year to Date
Jun 19 / Zacks.com - Paid Partner Content
Novartis Announces Positive Results for Cardiovascular Drug
Jun 22 / Zacks.com - Paid Partner Content
Puma (PBYI) Stock Surges as Neratinib Nears FDA Approval
Jun 15 / Zacks.com - Paid Partner Content
Healthcare Leads as Stocks Turn Higher After Release of Senate Bill
Jun 22 / TheStreet.com - Paid Partner Content
Novartis (NVS) Announced Positive Data on Psoriasis Cosentyx
Jun 15 / Zacks.com - Paid Partner Content
Stock Futures Dip as Crude Oil Looks to Correct Days-Long Slide
Jun 22 / TheStreet.com - Paid Partner Content
Why Is ImmunoGen (IMGN) Stock Up 131% This Year?
Jun 15 / Zacks.com - Paid Partner Content
Novartis Shares Lead Swiss Market Higher After CANTOS Trial Success
Jun 22 / TheStreet.com - Paid Partner Content
Why is Alnylam's (ALNY) Stock Close to 100% this Year?
Jun 15 / Zacks.com - Paid Partner Content
Ligand Gets Milestone Payment on Partner Drug FDA Approval
Jun 21 / Zacks.com - Paid Partner Content
Coherus Stock Plummets as FDA Rejects Neulasta Biosimilar
Jun 13 / Zacks.com - Paid Partner Content
FDA Commisoner Takes on Big Pharma
Jun 21 / TheStreet.com - Paid Partner Content
Novartis Presents Positive Data on CAR-T Cell Therapy Drug
Jun 12 / Zacks.com - Paid Partner Content
Novartis Migraine Drug Accepted, AMD Positive in Phase III
Jun 21 / Zacks.com - Paid Partner Content